137 related articles for article (PubMed ID: 36647577)
1. Assessing the risk of magnetic interaction between auditory implants and programmable ventriculoperitoneal shunts.
Shrivastava M; Abdul-Hamid A; Zilani G; Qureishi A; Jeyaretna S; Mackeith S
Cochlear Implants Int; 2023 Mar; 24(2):83-86. PubMed ID: 36647577
[TBL] [Abstract][Full Text] [Related]
2. Programmable shunt valve interactions with osseointegrated hearing devices.
J Neurosurg Pediatr; 2017 Apr; 19(4):384-390. PubMed ID: 28186475
[TBL] [Abstract][Full Text] [Related]
3. Cochlear implantation for total deafness after ipsilateral ventriculoperitoneal shunt surgery: technical report.
An YH; Song SJ; Yoon SW; Kim JH; Shim HJ
Acta Neurochir (Wien); 2011 Dec; 153(12):2479-83; discussion 2483. PubMed ID: 21989777
[TBL] [Abstract][Full Text] [Related]
4. Cochlear implantation in the presence of a programmable ventriculoperitoneal shunt.
Wiet RM; El-Kashlan HK
Otol Neurotol; 2009 Sep; 30(6):704-7. PubMed ID: 19638947
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging-related programmable ventriculoperitoneal shunt valve setting changes occur often.
Ucisik FE; Simonetta AB; Bonfante-Mejia EM
Acta Neurochir (Wien); 2022 Feb; 164(2):495-498. PubMed ID: 34787715
[TBL] [Abstract][Full Text] [Related]
6. Approach to Cochlear Implantation in Patients With Ventriculoperitoneal Shunts.
Macielak RJ; Selleck AM; Kocharyan A; Hunter JB; Patro A; Perkins EL; Hamilton CA; Patel NS; Gurgel RK; Sweeney AD; Brown KD; Link MJ; Carlson ML
Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1485-1493. PubMed ID: 36939465
[TBL] [Abstract][Full Text] [Related]
7. Effect of exposure from iPhone 12 on programmable ventriculoperitoneal shunts.
Kumar A; Pervaiz A; Borg A; Abdul-Hamid A; Jeyaretna S; MacKeith S; Qureishi A
Br J Neurosurg; 2022 Jun; 36(3):415-419. PubMed ID: 35062838
[TBL] [Abstract][Full Text] [Related]
8. Effect of audiological testing on programmable ventriculoperitoneal shunts.
Abdul-Hamid A; Zilani G; Bryant C; Bryant A; Qureishi A; Jeyaretna S; MacKeith S
Int J Audiol; 2022 Feb; 61(2):173-176. PubMed ID: 33586553
[TBL] [Abstract][Full Text] [Related]
9. Safety and function of programmable ventriculo-peritoneal shunt valves: An in vitro 7 Tesla magnetic resonance imaging study.
Chen B; Dammann P; Jabbarli R; Sure U; Quick HH; Kraff O; Wrede KH
PLoS One; 2023; 18(10):e0292666. PubMed ID: 37819939
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Using Hearing Aids and Hearing Assistive Technologies on Programmable Ventriculoperitoneal Shunt.
Ozdemir O; Yaz G; Diren F; Boyali O; Chasan M; Develioglu NO; Kabatas S; Civelek E
World Neurosurg; 2022 Nov; 167():e567-e574. PubMed ID: 35995353
[TBL] [Abstract][Full Text] [Related]
11. Lumboperitoneal Shunt: A New Modified Surgical Technique and a Comparison of the Complications with Ventriculoperitoneal Shunt in a Single Center.
Yang TH; Chang CS; Sung WW; Liu JT
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31561485
[No Abstract] [Full Text] [Related]
12. Early programmable valve malfunctions in pediatric hydrocephalus.
Mangano FT; Menendez JA; Habrock T; Narayan P; Leonard JR; Park TS; Smyth MD
J Neurosurg; 2005 Dec; 103(6 Suppl):501-7. PubMed ID: 16383248
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and indication for changing the primary valve opening pressure in ventriculoperitoneal shunts - A single center five years overview.
Müggenburg L; Behmanesh B; Dinc N; Marquardt G; Seifert V; Quick-Weller J
Clin Neurol Neurosurg; 2019 Nov; 186():105523. PubMed ID: 31525716
[TBL] [Abstract][Full Text] [Related]
14. Hearing loss following ventriculoperitoneal shunt in communicating hydrocephalus patients: a pilot study.
Lim HW; Shim BS; Yang CJ; Kim JH; Cho YH; Cho YS; Kong DS; Koo JW; Han JH; Chung JW
Laryngoscope; 2014 Aug; 124(8):1923-7. PubMed ID: 24318317
[TBL] [Abstract][Full Text] [Related]
15. Programmable valve shunts: are they really better?
Kataria R; Kumar V; Mehta VS
Turk Neurosurg; 2012; 22(2):237-8. PubMed ID: 22437300
[TBL] [Abstract][Full Text] [Related]
16. Use of programmable versus nonprogrammable shunts in the management of hydrocephalus secondary to aneurysmal subarachnoid hemorrhage: a retrospective study with cost-benefit analysis.
Lee L; King NK; Kumar D; Ng YP; Rao J; Ng H; Lee KK; Wang E; Ng I
J Neurosurg; 2014 Oct; 121(4):899-903. PubMed ID: 24745705
[TBL] [Abstract][Full Text] [Related]
17. Interactions between programmable shunt valves and magnetically controlled growing rods for scoliosis.
Larrew T; Alshareef M; Murphy RF; Eskandari R; Kosnik Infinger L
J Neurosurg Pediatr; 2020 Oct; 26(6):667-670. PubMed ID: 33007746
[TBL] [Abstract][Full Text] [Related]
18. Scalp necrosis overlying a ventriculoperitoneal shunt: a case report and literature review.
Nguyen TA; Cohen PR
Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632796
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with cochlear implants and ventriculoperitoneal shunts.
Chadwick KA; Moore J; Tye GW; Coelho DH
Cochlear Implants Int; 2014 Jul; 15(4):185-90. PubMed ID: 24144174
[TBL] [Abstract][Full Text] [Related]
20. The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts.
Oberheim-Bush NA; Shi W; McDermott MW; Grote A; Stindl J; Lustgarten L
J Neurooncol; 2022 Jul; 158(3):453-461. PubMed ID: 35639236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
